AU2001271050A1 - Method of collecting viral envelope from germinating baculovirus - Google Patents
Method of collecting viral envelope from germinating baculovirusInfo
- Publication number
- AU2001271050A1 AU2001271050A1 AU2001271050A AU7105001A AU2001271050A1 AU 2001271050 A1 AU2001271050 A1 AU 2001271050A1 AU 2001271050 A AU2001271050 A AU 2001271050A AU 7105001 A AU7105001 A AU 7105001A AU 2001271050 A1 AU2001271050 A1 AU 2001271050A1
- Authority
- AU
- Australia
- Prior art keywords
- viral envelope
- collecting viral
- germinating
- baculovirus
- germinating baculovirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000215416A JP2002030098A (ja) | 2000-07-17 | 2000-07-17 | バキュロウィルスの発芽ウイルスからウイルスエンベロープを回収する方法 |
| JP2000-215416 | 2000-07-17 | ||
| PCT/JP2001/006109 WO2002006305A1 (fr) | 2000-07-17 | 2001-07-16 | Procede permettant de recueillir l'enveloppe virale d'un baculovirus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001271050A1 true AU2001271050A1 (en) | 2002-01-30 |
Family
ID=18710842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001271050A Abandoned AU2001271050A1 (en) | 2000-07-17 | 2001-07-16 | Method of collecting viral envelope from germinating baculovirus |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2002030098A (fr) |
| AU (1) | AU2001271050A1 (fr) |
| WO (1) | WO2002006305A1 (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2500661A1 (fr) | 2002-10-01 | 2004-04-15 | Chiron Corporation | Compositions anticancereuses et contre les maladies infectieuses, et procedes d'utilisation correspondants |
| AU2005211385B2 (en) | 2004-02-02 | 2008-12-11 | Ambrx, Inc. | Modified human growth hormone polypeptides and their uses |
| BRPI0512235A (pt) | 2004-06-18 | 2008-02-19 | Ambrx Inc | polipeptìdeos ligadores de antìgenos e seus usos |
| MX2007000728A (es) | 2004-07-21 | 2007-03-15 | Ambrx Inc | Polipeptidos biosinteticos que utilizan amino acidos no naturalmente codificados. |
| KR20070090023A (ko) | 2004-12-22 | 2007-09-04 | 암브룩스, 인코포레이티드 | 변형 인간 성장 호르몬 |
| AU2005319518B2 (en) | 2004-12-22 | 2010-09-09 | Ambrx, Inc. | Compositions of aminoacyl-tRNA synthetase and uses thereof |
| SG161209A1 (en) | 2004-12-22 | 2010-05-27 | Ambrx Inc | Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| MX2007007591A (es) | 2004-12-22 | 2007-07-25 | Ambrx Inc | Metodos para expresion y purificacion de hormona de crecimiento humano recombinante. |
| EP1828224B1 (fr) | 2004-12-22 | 2016-04-06 | Ambrx, Inc. | Compositions contenant des acides amines non naturels et des polypeptides, procedes impliquant ces acides amines non naturels et polypeptides, et utilisations desdits acides amines non naturels et polypeptides |
| CA2609205A1 (fr) | 2005-06-03 | 2006-12-14 | Ambrx, Inc. | Molecules d'interferons humains ameliorees et utilisations de celles-ci |
| US20090018029A1 (en) | 2005-11-16 | 2009-01-15 | Ambrx, Inc. | Methods and Compositions Comprising Non-Natural Amino Acids |
| CA2663083A1 (fr) | 2006-09-08 | 2008-03-13 | Ambrx, Inc. | Polypeptide plasmatique humain modifie ou squelettes de fc et leurs utilisations |
| MX2009002526A (es) | 2006-09-08 | 2009-04-16 | Ambrx Inc | Transcripcion de tarn supresor en celulas de vertebrados. |
| ES2385114T3 (es) | 2007-03-30 | 2012-07-18 | Ambrx, Inc. | Polipéptidos de FGF-21 modificados y sus usos |
| CA2685596A1 (fr) | 2007-05-02 | 2008-11-13 | Ambrx, Inc. | Polypeptides d'interferon beta modifies et leurs utilisations |
| ES2632504T3 (es) | 2007-11-20 | 2017-09-13 | Ambrx, Inc. | Polipéptidos de insulina modificados y sus usos |
| US9938333B2 (en) | 2008-02-08 | 2018-04-10 | Ambrx, Inc. | Modified leptin polypeptides and their uses |
| EP2318029B1 (fr) | 2008-07-23 | 2017-11-01 | Ambrx, Inc. | Polypeptides g-csf bovins modifiés et leurs utilisations |
| MX357314B (es) | 2008-09-26 | 2018-07-04 | Ambrx Inc | Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales. |
| NZ592250A (en) | 2008-09-26 | 2012-11-30 | Lilly Co Eli | Modified animal erythropoietin polypeptides and their uses |
| US20120283172A1 (en) | 2009-12-21 | 2012-11-08 | Ambrx, Inc. | Modified porcine somatotropin polypeptides and their uses |
| US20120283171A1 (en) | 2009-12-21 | 2012-11-08 | Ambrx, Inc. | Modified bovine somatotropin polypeptides and their uses |
| US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
| HUE045845T2 (hu) | 2010-08-17 | 2021-12-28 | Ambrx Inc | Módosított relaxin polipeptidek és felhasználásuk |
| TWI480288B (zh) | 2010-09-23 | 2015-04-11 | Lilly Co Eli | 牛顆粒細胞群落刺激因子及其變體之調配物 |
| PE20170950A1 (es) | 2014-10-24 | 2017-07-13 | Bristol Myers Squibb Co | Polipeptidos del factor de crecimiento de fibroblastos 2 (fgf-21) modificados y usos de los mismos |
| CA3052639A1 (fr) | 2017-02-08 | 2018-08-16 | Bristol-Myers Squibb Company | Polypeptides de relaxine modifies comprenant un activateur pharmacocinetique et leurs utilisations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL84154A0 (en) * | 1986-10-16 | 1988-03-31 | Microgenesys Inc | Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same |
| FR2700957B1 (fr) * | 1993-01-29 | 1995-03-03 | Seppic Sa | Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation. |
| EP1845108A3 (fr) * | 1994-07-29 | 2007-10-24 | Innogenetics N.V. | Anticorps monoclonaux de protéines d'enveloppe de virus de l'hépatite C purifiée pour l'utilisation de diagnostic et thérapeutique |
| AU738585B2 (en) * | 1996-11-08 | 2001-09-20 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Synthesis and purification of hepatitis C virus-like particles |
| FR2761994B1 (fr) * | 1997-04-11 | 1999-06-18 | Centre Nat Rech Scient | Preparation de recepteurs membranaires a partir de baculovirus extracellulaires |
-
2000
- 2000-07-17 JP JP2000215416A patent/JP2002030098A/ja active Pending
-
2001
- 2001-07-16 AU AU2001271050A patent/AU2001271050A1/en not_active Abandoned
- 2001-07-16 WO PCT/JP2001/006109 patent/WO2002006305A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002006305A1 (fr) | 2002-01-24 |
| JP2002030098A (ja) | 2002-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001271050A1 (en) | Method of collecting viral envelope from germinating baculovirus | |
| AU2002221142A1 (en) | Semiconductor photocathode | |
| AU2001275938A1 (en) | Cardiac photoablation instruments | |
| AU2002356951A1 (en) | Photocathode | |
| AU2217001A (en) | Intramedullary support strut | |
| AU6111000A (en) | Inhibitors of viral helcase | |
| AU2557500A (en) | Methods of making compounds | |
| AU3771000A (en) | Method of promoting angiogenesis | |
| AU4062299A (en) | Electron tube | |
| AU2002215217A1 (en) | Semiconductor photocathode | |
| AU2002361435A1 (en) | Method for making electrodes and vacuum tube using same | |
| EP1160303A3 (fr) | Procédé de fabrication d'une feuille de phosphore stimulable | |
| AU2982000A (en) | Preparation of 9-hydrocarbyl-9-phosphabicyclononanes | |
| AU2001292947A1 (en) | Methods for inhibition of viral infection | |
| AU2001294173A1 (en) | Method of screening physiologically active substance | |
| AU1389801A (en) | Modification of plants | |
| AU6551800A (en) | Dinucleoside 5',5'-tetraphosphates as inhibitors of viral reverse transcriptasesand viruses | |
| AU2001276523A1 (en) | Aspiration of samples | |
| AU2073899A (en) | Electron tube | |
| AU3757200A (en) | Treatment of pulmonary hypertension | |
| AU2002357517A1 (en) | Reply-paid envelope | |
| AU2001284437A1 (en) | Envelope | |
| AU5298100A (en) | Preparation of enantio-specific epoxides | |
| AU2002222316A1 (en) | Process for the preparation of zafirlukast | |
| AU2002216038A1 (en) | Preparation of monofluoroalkenes |